The 4 analysts offering 12-month price forecasts for Theratechnologies Inc have a median target of 2.93, with a high estimate of 6.20 and a low estimate of 2.47. The median estimate represents a +27.73% increase from the last price of 2.29.
The current consensus among 4 polled investment analysts is to Hold stock in Theratechnologies Inc. This rating has held steady since July, when it was unchanged from a Hold rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.12
Reporting Date Oct 13
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.